Overcoming COVID-19 disruptions: Innovations in product provision in a multi-national clinical trial among cisgender men, transgender men and transgender women in five countries-Reference-Cited by-同舟云学术

Overcoming COVID-19 disruptions: Innovations in product provision in a multi-national clinical trial among cisgender men, transgender men and transgender women in five countries

Published:2022-08 Issue: Volume:28 Page:100930
ISSN:2451-8654
Container-title:Contemporary Clinical Trials Communications
language:en
Short-container-title:Contemporary Clinical Trials Communications

Author:

Cindy Jacobson^ORCID,Sherri Johnson,Tarana Billups,Lynn Mitterer,Mary Chadza,Sibuiswe Gumede,Veruree Manoyos,Karina Pareja,Jillian Zemanek,Yuqing Jiao,Jose Bauermeister

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference13 articles.

1. Heterosexual transmission of human immunodeficiency virus: variability of infectivity throughout the course of infection. European Study Group on Heterosexual Transmission of HIV;Leynaert;Am. J. Epidemiol.,1998

2. Per-contact risk of human immunodeficiency virus transmission between male sexual partners;Vittinghoff;Am. J. Epidemiol.,1999

3. HIV Testing and Risk Behaviors Among Gay, Bisexual, and Other Men Who Have Sex with Men – United States,2013

4. Trends in condom use and risk behaviours after sexual exposure to HIV: a seven-year observational study;Casalino;PLoS One,2014

5. Changing patterns of sexual behaviour in the era of highly active antiretroviral therapy;Elford;Curr. Opin. Infect. Dis.,2006

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A latent trajectory analysis of young sexual and gender minorities’ adherence to three rectal microbicide placebo formulations (MTN-035; a randomized crossover trial);BMC Public Health;2023-12-08

2. A randomized trial of safety, acceptability and adherence of three rectal microbicide placebo formulations among young sexual and gender minorities who engage in receptive anal intercourse (MTN-035);PLOS ONE;2023-04-12